Mercy Community Healthcare Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2595 Fairview Blvd, Fairview, TN 37062 Phone: 615-790-0567 Fax: 615-595-8030 |
Mercy Community Healthcare Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7200 Tiger Trl, Fairview, TN 37062 Phone: 615-790-0567 Fax: 615-595-8030 |
Mercy Community Healthcare Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2640 Fairview Blvd, Fairview, TN 37062 Phone: 615-790-0567 |
Mercy Community Healthcare Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7200 Cumberland Dr, Fairview, TN 37062 Phone: 615-790-0567 Fax: 615-595-8030 |
Tlmcc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2014 Fairview Blvd, Suite 102, Fairview, TN 37062 Phone: 615-473-2611 |
Milligan & Associates Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7117 Brush Creek Rd, Fairview, TN 37062 Phone: 615-351-0125 |
Piece Of Mind Learning Center, Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 7506 Cherokee Hills Rd, Fairview, TN 37062 Phone: 615-207-4191 |
News Archive
The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.
Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled "Apparatus and Methods for Assessing Metabolic Substrate Utilization" to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.
A study conducted at the University of Arizona College of Pharmacy found that only 28 percent of pharmacies' clinical decision support software systems - the computer programs that are in place to alert pharmacists to possible medication problems - correctly identified potentially dangerous drug-drug interactions.
InterMune, Inc. today announced that Health Canada has approved Esbriet (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) in adult patients.
Columbia University Medical Center will present the 2010 Naomi Berrie Award to a Harvard researcher who has made important advances in understanding the molecular basis for links between obesity, diabetes and heart disease. A promising young investigator at Columbia will also be recognized for her novel investigations regarding the basis for disordered lipid metabolism in diabetes.
› Verified 8 days ago